ArticleFrontiers in chemistry2023

Pb-214/Bi-214-TCMC-Trastuzumab inhibited growth of ovarian cancer in preclinical mouse models.

Abdullah Metebi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.